|
Jan 10
|
JPM's annual healthcare conference: Here's what's next for GLP-1s and the weight loss market
|
|
Jan 10
|
Gen X drugmaker is coughing up millions for Paris Olympics sponsorship to show Gen Z and millennials it’s a cool place to work
|
|
Jan 10
|
Drugs group Sanofi makes Olympic jump in rebrand bid
|
|
Jan 9
|
Press Release: Brian Foard appointed Head of Specialty Care Global Business Unit, member of Sanofi Executive Committee
|
|
Jan 2
|
MeiraGTx (MGTX) Stock Surges 35% in a Month: Here's Why
|
|
Jan 2
|
China Approves AstraZeneca-Sanofi's Respiratory Syncytial Virus Drug To Prevent Infection In Infants
|
|
Jan 1
|
Here's Why Sanofi (SNY) is a Strong Value Stock
|
|
Dec 29
|
Expensive Drugs For Americans In 2024? Drugmakers Including Pfizer, Sanofi Mull Price Increase In January
|
|
Dec 29
|
How Lowering The Price of a Common Asthma Drug Made It Harder to Get
|
|
Dec 24
|
15 Undervalued Defensive Stocks For 2024
|
|
Dec 22
|
Sanofi (SNY) Discontinues Tusamitamab Ravtansine Cancer Program
|
|
Dec 22
|
Pharma Stock Roundup: FDA Nod to AZN's Eplontersen, CRL to MRK's Cough Candidate
|
|
Dec 21
|
Sanofi scraps a top ADC prospect after study setback
|
|
Dec 21
|
Press Release: Sanofi announces end of program evaluating tusamitamab ravtansine after a 2L NSCLC Phase 3 trial did not meet a primary endpoint
|
|
Dec 19
|
13 Most Promising Healthcare Stocks According to Analysts
|
|
Dec 18
|
Sanofi: Information concerning the total number of voting rights and shares - November 2023
|
|
Dec 18
|
UPDATE 2-US antitrust enforcers release final version of new merger guidelines
|
|
Dec 18
|
Sanofi: The Current Price Makes No Sense
|
|
Dec 15
|
UPDATE 1-Sanofi gets positive EMA opinion for sleeping sickness treatment
|
|
Dec 15
|
Press Release: Availability of the Q4 2023 Memorandum for modelling purposes
|